Secondary’s Announced 2.5.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here.

Company: Ohr Pharmaceutical, Inc.
Symbol: OHRP
Price: Last trade $7.64
Trade Date: 2/6
Shares: TBD
Underwriter(s) Cowen & Co.
Co Manager(s) LifeSci Capital
Rating=Subscription Needed

Company: Navios Maritime
Symbol: NMM
Price: Last trade $13.71
Trade Date: 2/6
Shares: 4 million
Underwriter(s) BofA Merrill Lynch, Citigroup, J.P. Morgan, Deutsche Bank, Credit Suisse
Co Manager(s) S. Goldman Capital
Rating=Subscription Needed

Company: TrovaGene, Inc.
Symbol: TROV
Price: Last trade $5.85
Trade Date: 2/6
Shares: 3.4 million
Underwriter(s) Piper Jaffray
Rating=Subscription Needed